Skip to main content

Sangamo Therapeutics, Inc 8-K, filed Oct 27, 2026

Sangamo Therapeutics, Inc (SGMOQ)

8-K 2026-10-27 For: 2026-10-23
View Original
Added on October 27, 2026

About this 8-K

Sangamo Therapeutics, Inc filed this 8-K on October 27, 2026, reporting on events of October 23, 2026.

Sangamo Therapeutics, Inc. filed amended July and August monthly operating reports and a September report for its bankruptcy case; its common stock was delisted effective October 17, 2026. AI summary

Items reported

  • Item 7.01: Regulation FD disclosure
  • Item 9.01: Financial statements and exhibits